With the sector under pressure to improve patient outcomes while controlling costs, artificial intelligence and machine learning are quickly becoming indispensable tools. These technologies show promise for supporting decision-making, enhancing the delivery of care, and personalizing medicine, while also revolutionizing medical research by giving scientists access to unprecedented amounts of data that could lead to novel treatments or cures for diseases.
To help navigate this dynamic era, Foley has launched its AI in Health Care Series to guide health care organizations deploying AI-based solutions. Our contributors will examine this intersection through lenses including its impact on merger activity, antitrust enforcement, patent prosecution, and more.
